Hengrui Pharma (01276) has announced a key executive change, with the appointment of Tian Fei as the company's new Board Secretary.

The decision was formally ratified during the fourth meeting of the tenth Board of Directors, held on August 19, 2026. The move followed a nomination by the company's Chairman and subsequent approval by the Board's Nomination Committee.

The appointment was confirmed through the board's deliberation and passage of the "Proposal on the Change of the Company's Board Secretary." With this resolution, Tian Fei officially assumes the role, succeeding in the position as part of the company's ongoing corporate governance enhancements.